ArticlePloS one2026
Astrovirus in the Brazilian Amazon: First detection of non-classical astroviruses (MLB-3) in the Americas.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human astrovirus (HAstV) is a viral agent responsible for acute gastroenteritis (AGE), primarily affecting children and the elderly worldwide. Belonging to the Astroviridae family, HAstV is classified into eight classical serotypes (HAstV 1-8) and two other divergent non-classical clades: Melbourne (MLB 1-3) and Virginia (VA 1-6), which have been associated with gastroenteritis, central nervous system complications, and acute respiratory disease. This study aimed to investigate the frequency of classical and non-classical HAstV in fecal specimens collected from children up to 14 years of age in northern Brazil, within the Amazon region, between 2013 and 2022. A total of 560 samples, all previously tested negative for other gastroenteric viruses such as rotavirus and norovirus, were analyzed using reverse transcription followed by quantitative polymerase chain reaction (RT-qPCR) and conventional RT-PCR. For classical HAstV, 10.7% (60/560) of the samples were positive by RT-qPCR and 2.0% (11/560) to 3.0% (17/560) by conventional RT-PCR using different primers set. Non-classical HAstV was detected in 0.2% (1/560) of the samples. Diarrhea was present in 91.7% of positive cases, vomiting in 71.7%, and fever in 53.3%. The most affected age group was children aged >5-10 years (25.0%), with no significant association between infection rate and sex. A higher number of infections occurred during the Amazon winter (11.6%), with Roraima identified as the federative unit with the highest number of cases. Fifteen samples (88.2%, 15/17) were sequenced and identified as classical HAstV, with the following genotypes detected: HAstV-1 (60.0%, 9/15), HAstV-3 (20.0%, 3/15), and HAstV-4 (20.0%, 3/15). Non-classical HAstV sequencing was performed on 12 (93.2%, 12/13) positive specimens, characterized as HAstV-1 (50%, 6/12), HAstV-3 (25%, 3/12), HAstV-4 (16.7%, 2/12), and HAstV-MLB-3 (8.3%, 1/12). A probable recombinant strain was identified, classified as HAstV-4 based on the ORF2 region and HAstV-1 based on the ORF1b region. This study provides updated epidemiological data on HAstV in the Brazilian Amazon and highlights the genetic diversity of both classical and non-classical genotypes. Notably, it reports the first detection - and the second complete genome repository - of the rare MLB-3 genotype in the Americas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.